GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Kahn Swick & Foti announced a class action lawsuit against GeneDx Holdings, reminding investors of an August 3 deadline to file lead plaintiff applications regarding alleged securities fraud. The complaint claims the company failed to disclose material information between April 2025 and May 2026, specifically regarding the performance of its acquisition of Fabric Genomics.
Key figures
- Guidance new
- $475 - $490 million
- Guidance old
- $540 - $550 million
- Impairment loss
- $31.2 million
- Stock decline pct
- 49.2%
- Lead plaintiff deadline
- August 3, 2026
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.